Asymptomatic Carotid Lesions and Cognitive Impairment: Does Intervention Play a Role?

This study was designed to determine the effect of carotid endarterectomy/angioplasty on early (baseline vs. 3 months) and late (baseline vs. >5 months) cognitive function in patients with asymptomatic lesions.

This systematic research included 31 non-randomized studies.

Regarding the immediate post-operative period, 24 of these papers reported significant improvement in cognitive function; one study reported significant deterioration; three showed mixed results (some scores improved and others worsened), and the rest showed no changes.

In the late post-operative period (that is, well after endarterectomy or angioplasty), one study reported worse cognitive function, another showed significant improvement, some obtained mixed results, and most showed no change from baseline.

These results showed a similar distribution when comparing small studies with larger ones, controlled vs. uncontrolled studies, studies that used endarterectomy vs. others that used angioplasty, and studies with longer or shorter follow-up.


Read also: HOST-EXAM: The Study that Challenges Aspirin as Long-Term Antiplatelet Therapy.


Conclusion

Intervention, whether it be endarterectomy or angioplasty, rarely improves long-term cognitive function (<2%). However, it rarely makes it worse (in fact, magnitude is similar: 2%).

In the long term, the vast majority of papers (69%) could not prove an improvement in cognitive function. Only a few studies indicated improvement. The rest reported no change.

Until we have new papers that better identify the most vulnerable patients (with poor functional reserve) or provide clear evidence that silent embolism from a diseased carotid artery does indeed lead to cognitive impairment, we will remain in a sea of speculation.

Original title: Effect of Carotid Interventions on Cognitive Function in Patients With Asymptomatic Carotid Stenosis: A Systematic Review.

Reference: Stefano Ancetti et al. Eur J Vasc Endovasc Surg. 2021 Aug 30;S1078-5884(21)00604-3. Online ahead of print. doi: 10.1016/j.ejvs.2021.07.012. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Chronic Thromboembolic Pulmonary Hypertension: Treatment Outcomes According to a Worldwide Registry

Chronic thromboembolic pulmonary hypertension (CTEPH) is a highly limiting condition that, despite its moderate incidence, significantly impacts patient prognosis and quality of life. The...

Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as a sudden occlusion of limb perfusion compromising...

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....